Article Name Clinical Trials and Research
Argá Medtech’s Vision for Safer, Scalable AF Ablation
Argá Medtech, developer of the Coherent Sine-Burst Electroporation™ (CSE™) System—a next-generation PFA platform designed to expand treatment possibilities while simplifying workflows for physicians
29th September, 2025
Olympus Initiates Global Removal of ViziShot 2 FLEX Needles Following Safety Reports
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.
23rd September, 2025
PHASE Scientific Launches World’s Largest Clinical Study on Urine-Based Cervical Cancer Screening in China
The 17,000-woman study, led by Peking University Shenzhen Hospital, sets three world records and integrates PHASiFY™ DNA concentration technology with AI-powered diagnostics to advance scalable, non-invasive screening in line with WHO’s 2030 elimination goals.
23rd September, 2025
Techsomed Secures FDA 510(k) Clearance for BioTraceIO360 Kidney Ablation Indication
The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care.
23rd September, 2025
PHASE Scientific Launches Urine-Based Cervical Cancer (HPV) Screening Clinical Study
The study applies PHASE Scientific’s proprietary PHASiFY urine-based DNA concentration technology
22nd September, 2025
HeartcoR Solutions Expands Suite of Remote Patient Monitoring Devices
The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as a leading core lab for remote patient monitoring (RPM)
19th September, 2025
Argá Medtech Announces Enrollments in COHERENT-AF IDE Clinical Trial
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe
19th September, 2025
China’s Healthcare Investment Climate: Rebalancing Global and Local Innovation
Yang Huang, Head of China Healthcare Research at J.P. Morgan, unpacks how favourable policies, demographic shifts, and global collaborations are shaping the future of biopharma and medtech investment in China.
19th September, 2025
Max Healthcare partners with Medtronic to launch state-of-the-art surgical skill lab
This strategic collaboration aims to advance medical education and clinical training in laparoscopic and minimally invasive surgical techniques
18th September, 2025
ZKR Orthopaedics Announces First Patella LIFT Surgeries on the East Coast at Hospital
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial
17th September, 2025
New Zealand’s Wellumio Launches Equity Crowdfunding To Revolutionise Stroke Care With Portable Brain Scanner
Medtech firm unveils Axana®, a 50kg, AI-enhanced, portable MRI device that cuts stroke diagnosis time by over 90%—unlocking lifesaving treatment in the golden hour and opening an $8.9bn global market opportunity.
16th September, 2025
Prinses Máxima Centre for Pediatric Oncology Implements Callisto from Volta Labs to Streamline Clinical Genomics Workflows
The Prinses Máxima Centre is the largest pediatric cancer centre in Europe, dedicated to integrating care and research to improve outcomes for children with cancer
11th September, 2025
Altesa BioSciences and bioMérieux Collaborate for Altesa's Upcoming Phase 2B COPD Clinical Trial
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites
10th September, 2025
Vivalink Introduces Adhesive for Wearable ECG to Enhance Ambulatory Cardiac Monitoring
Improves p-wave signal detection up to 160%, helping clinicians identify atrial abnormalities to prevent future adverse cardiac events
10th September, 2025
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C
Robust 24-month complete response (CR) rate of 41.8 per cent observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment
08th September, 2025
Vivos Files Critical Patent for Hydrogel Electron Beam Sterilisation
The validation was carried out under ISO 11137 by an international medical device accredited organisation
04th September, 2025
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Sleep Institute publishes original research, expert perspectives, and real-world data to support earlier and more accurate diagnosis and guide more informed clinical, policy
04th September, 2025
Siemens Healthineers and Evident Partner with Klinikum Ludwigshafen to Deliver Fully Digital Pathology Workflow
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.
04th September, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer